Economic impact of medication non-adherence by disease groups: a systematic review.

ABSTRACT:

Objective

To determine the economic impact of medication non-adherence across multiple disease groups.

Design

Systematic review.

Evidence review

A comprehensive literature search was conducted in PubMed and Scopus in September 2017. Studies quantifying the cost of medication non-adherence in relation to economic impact were included. Relevant information was extracted and quality assessed using the Drummond checklist.

Results

Seventy-nine individual studies assessing the cost of medication non-adherence across 14 disease groups were included. Wide-scoping cost variations were reported, with lower levels of adherence generally associated with higher total costs. The annual adjusted disease-specific economic cost of non-adherence per person ranged from $949 to $4

SUBMITTER: Cutler RL 

PROVIDER: S-EPMC5780689 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature